MRI-compatible syringe pump market projected to reach $0.46 billion by 2030

The MRI-compatible syringe pump market is forecast to grow from $0.32 billion in 2025 to $0.46 billion by 2030, driven by rising MRI use, chronic disease burden and demand for safer contrast delivery. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - MRI-compatible syringe pumps help deliver medications and contrast agents during scans without interfering with MRI imaging. - Demand is rising as hospitals and diagnostic centers seek safer, more precise infusion during MRI procedures. - The market’s projected growth signals more spending on MRI infrastructure, smart infusion systems and non-magnetic device designs.

What happened: - The MRI-compatible syringe pump market is projected to increase from $0.32 billion in 2025 to $0.34 billion in 2026. - The market is forecast to reach $0.46 billion by 2030. - The forecast implies 7.5% CAGR from 2025 to 2026 and 7.7% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report is from The Business Research Company. - Download a free sample of the report. - View the full market report.

The details: - MRI-compatible syringe pumps are specialized infusion devices that administer precise volumes of fluids, drugs or contrast agents during MRI scans. - The devices use non-magnetic materials to avoid interference with MRI equipment and preserve image clarity. - The pumps can operate in continuous or programmable infusion modes. - Market growth has been driven by increased MRI diagnostics, higher demand for precise contrast agent delivery, stronger patient safety requirements and more advanced diagnostic facilities. - Growth is also linked to broader use of infusion systems in critical care settings. - Future growth drivers include MRI-guided procedures, programmable infusion technologies, smart monitoring features and healthcare infrastructure investment. - The report highlights a rise in MRI-compatible infusion devices, programmable syringe pumps, safer contrast administration, non-magnetic medical device innovation and continuous infusion protocols during MRI exams. - Chronic disease burden is a key catalyst because patients with multiple conditions often need coordinated, ongoing medication delivery. - CDC data cited in the report shows that in 2023, 76.4% of US adults had at least one chronic condition and 51.4% had multiple chronic illnesses. - MRI procedure volume is another driver because more scans increase demand for uninterrupted delivery of medications and contrast agents. - NIH data cited in the report shows CT imaging increased 60% and MRI activity increased 31% in December 2025.

Between the lines: - The market forecast points to a niche device category benefiting from two larger trends: more imaging and more chronic disease management. - The regional split suggests mature adoption in North America and faster buildout in markets still expanding imaging capacity. - The emphasis on programmable and smart features suggests buyers are prioritizing workflow control and patient safety, not just MRI compatibility.

What's next: - More hospitals and imaging centers are likely to add MRI-compatible infusion systems as MRI procedure volumes rise. - Product development is likely to focus on smarter monitoring, non-magnetic materials and programmable delivery features. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis. - The company lists Saumya Sahay as an expert contact for more information.

The bottom line: - MRI-compatible syringe pumps are moving from a specialized niche to a faster-growing part of the imaging equipment market as safety, precision and MRI volume all climb.